| Literature DB >> 35683594 |
Grazia D'Onofrio1, Nicoletta Trotta2, Melania Severo2, Salvatore Iuso2, Filomena Ciccone1, Anna Maria Prencipe1, Seyed Mohammad Nabavi3, Gabriella De Vincentis4, Annamaria Petito2.
Abstract
BACKGROUND: The study aim was to review the evidence and effectiveness of psychological interventions applied during Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic.Entities:
Keywords: anxiety; depression; psychological treatment; resilience; viral infection
Year: 2022 PMID: 35683594 PMCID: PMC9181132 DOI: 10.3390/jcm11113209
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.964
Figure 1Flow diagram outlining the selection procedure to identify articles which were included in the analysis of psychological interventions in SARS-CoV-2 pandemic emergency.
Figure 2Risk of bias in included studies.
A general overview of the included studies.
| Study | Pandemic | Country | Study Design | Sample Size | Sample Type | Age | Psychological Intervention Type | Number of Sessions Performed | Session Duration | Session Modality | Duration | Ref. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mellins et al. (2020) | SARS-CoV-2 | USA | VPS | 186 groups of 1–30 people (124 completed the survey) | Health care workers | ns | CBT | 30 groups met once 22 groups met 2–4 times 9 groups met ≥5 times | 30 min. | online | 3 months | [ |
| Wei et al. (2020) | SARS-CoV-2 | China | CCS | 26 participants | Patients | 40.8 ± 13.5 | ICBT | 1/day | 50 min. | online | 2 weeks | [ |
| Wahlund et al. (2021) | SARS-CoV-2 | Sweden | RCT | 335 participants | General population | 45.0 ± 13.0 | CBT | 5 modules | ns | online | 3 weeks + 1 month follow-up | [ |
| Malboeuf-Hurtubise et al. (2021) | SARS-CoV-2 | Canada | RCT | 37 children | Students | 8.2 ± ns | P4C | 1/week | 1 h | online | 5 weeks | [ |
| Shaygan et al. (2021) | SARS-CoV-2 | Iran | cRPC | 26 participants | Patients | 36.8 ± 11.8 | OMPI | 1/day | 1 h | online | 2 weeks | [ |
| Al-Alawi et al. (2021) | SARS-CoV-2 | Oman | opRCT | 22 participants | Patients | 28.5 ± 8.7 | CBT | 1/week | 1 h | online | 6 weeks | [ |
| Perri et al. (2021) | SARS-CoV-2 | Italy | RCT | 38 participants | Patients | 48.3 ± 13.6 | EMDR | 2/week | ns | online | 3 weeks + 1 month follow-up | [ |
| Liu et al. (2021) | SARS-CoV-2 | China | PM2aRCT | 126 participants | Patients | 43.8 ± 14.3 | cCBT + TAU | 1/day | 10 min. | online | 1 week + | [ |
| Song et al. (2021) | SARS-CoV-2 | China | L2aCT | 83 participants | Patients | 34.6 ± 9.1 | MiCBT | 1/week | 30 min. | online | 3 weeks | [ |
| Wasil et al. (2021) | SARS-CoV-2 | USA | RCT | 189 participants | Students | 31.0 ± 8.9 | COMET (based on CBT + gratitude intervention) | Single session | 20–25 min. | online | ns | [ |
| Al-Refae et al. (2021) | SARS-CoV-2 | Canada | RCT | 78 participants | Patients | 26.1 ± 8.4 | MBI SERENE | At least 1/day | ns | online | 4 weeks | [ |
| Schlarb et al. (2021) | SARS-CoV-2 | Germany | Pilot study | 9 participants | Adults | 42.0 ± ns | iCBT-I | 1/week | 8.34 ± 2.32 | online | 7 weeks | [ |
Legend: VPS, validation protocol study; CCS, case–control study; RCT, randomized controlled trial; cRPC, cluster randomized parallel controlled; opRCT, Open-label, Pragmatic, Randomized Controlled Trial; PM2aRCT, prospective multicenter two-arm randomized controlled trial; L2aCT, longitudinal two-arm clinical trial; ns, not specified; CBT, cognitive behavioral therapy; ACT, acceptance and commitment therapy; ICBT, internet-delivered cognitive behavior therapy; MBI, mindfulness based interventions; P4C, philosophy for children; OMPI, online multimedia psychoeducational intervention; EMDR, eye movement desensitization and reprocessing; TF-CBT, trauma-focused cognitive behavioral therapy; cCBT, computerized cognitive behavioral therapy; TAU, treatment as usual; MiCBT, mobile internet cognitive behavioral therapy; COMET, Common Elements Toolbox; SERENE, self-compassion-based cognitive smartphone intervention; iCBT-I, Internet-based cognitive behavioral therapy for insomnia.
Visual display of outcomes table.
| Study | Ref. | PTSD | Depression | Anxiety | Primary/Secondary Coping | Functional Impairment | Intolerance of Uncertainty | Insomnia | Attention Deficit | Resilience | Perceived Stress | Performed Measures |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mellins et al. (2020) | [ | — | — | — | — | — | — | — | — | — | ↓ * | Survey Qualtrics |
| Wei et al. (2020) | [ | — | ↓ ** | ↓ ** | — | — | — | — | — | — | — | 17-HAMD |
| Wahlund et al. (2021) | [ | — | ↓ ** | ↓ ** | — | ↓ ** | ↓ ** | ↓ ** | — | — | — | GAD-7 |
| Malboeuf-Hurtubise et al. (2021) | [ | — | ↓ ** | ↓ ** | — | ↓ ** | — | — | ↓ ** | — | — | BASC III |
| Shaygan et al. (2021) | [ | — | — | — | — | — | — | — | — | ↑ * | ↓ * | CD-RISC |
| Al-Alawi et al. (2021) | [ | — | ↓ * | ↓ * | — | — | — | — | — | — | — | PHQ-9 |
| Perri et al. (2021) | [ | ↓ ** | ↓ ** | ↓ ** | — | — | — | — | — | — | — | PCL-5 |
| Liu et al. (2021) | [ | — | ↓ * | ↓ * | — | — | — | ↓ * | — | — | — | 17-HAMD |
| Song et al. (2021) | [ | — | ↓ * | ↓ * | — | — | — | ↓ * | — | — | — | PHQ-9 |
| Wasil et al. (2021) | [ | — | — | — | ↑ * | — | — | — | — | — | — | SCSC adapted 3-items |
| Al-Refae et al. (2021) | [ | — | ↓ * | ↓ * | ↑ * | — | — | — | — | — | ↓ * | DASS-21 |
| Schlarb et al. (2021) | [ | — | — | — | — | — | — | ↓ * | — | — | — | PSQI |
Legend: The arrows denote the direction of change in the mental health outcome measures. * = statistically significant result, whereby p ≤ 0.05; ** = statistically significant result, whereby p ≤ 0.01. 17-HAMD, 17-item Hamilton Depression Scale; HAMA, Hamilton Anxiety Scale; GAD-7, Generalized Anxiety Disorder seven item scale; MADRS-S, Montgomery Åsberg Depression Rating Scale – Self report; WSAS, Work and Social Adjustment Scale; IUS-12, Intolerance of Uncertainty Scale short version; ISI, Insomnia Severity Index; BASC III, Behavior Assessment Scale for Children-3rd edition, self-report scale; BPN, basic psychological need satisfaction; CD-RISC, Connor-Davidson resilience scale; PSS, Perceived Stress Scale; CSQ-I, client satisfaction questionnaire adapted to internet-based interventions; PHQ-9, Patient Health Questionnaire-9; PCL-5, post-traumatic stress disorder checklist for DSM 5; STAI-Y1, State Trait Anxiety Inventory; BDI-II, Beck Depression Inventory-II; SDS, Self-rating Depression Scale; SAS, Self-rating Anxiety Scale; AIS, Athens Insomnia Scale; VAS, visual analogue scale (anxiety self-rating scale of COVID-19); SCSC, Secondary Control Scale for Children; DASS-21, Depression, Anxiety, and Stress Scale; SD-WISE, San-Diego Wisdom scale; PWBS, Psychological Well-being scale; PSQI, Pittsburgh Sleep Quality Index.
Figure 3Forest plot of the psychological intervention effect during the SARS-CoV-2 pandemic Using Random Effects Model [20,21,22,23,24,25,26,27,28]. Squares indicate the OR of individual studies, and the extended lines denote 95% confidence intervals (CI). The diamond data indicates pooled prevalence. Test of heterogeneity: I2 = 99.99%, p = 0.00.